In pharmaceutical synthesis, some intermediates are valuable not simply because they appear in a particular API route, but because their molecular structure gives chemists several ways to build on them.

5-Bromo-2-chloropyrimidine (CAS 32779-36-5) is one such example.

This dihalogenated pyrimidine contains bromine at the 5-position and chlorine at the 2-position. The two halogen substituents have different reactivity profiles, creating opportunities for selective functionalisation during subsequent synthesis.

That combination makes 5-Bromo-2-chloropyrimidine a useful building block in pharmaceutical chemistry and an example of how the structure of an intermediate can influence the design of a synthetic route.

What Is 5-Bromo-2-Chloropyrimidine?

5-Bromo-2-chloropyrimidine is a dihalogenated pyrimidine derivative with:

• CAS Number: 32779-36-5
• Molecular Formula: C₄H₂BrClN₂
• Molecular Weight: 193.43 g/mol
• Chemical class: Dihalogenated pyrimidine

The molecule contains a six-membered pyrimidine ring with two nitrogen atoms, a bromine substituent at the 5-position and a chlorine substituent at the 2-position.

That substitution pattern is particularly useful because bromine and chlorine can display different reactivity under appropriate reaction conditions.

Instead of having two identical reactive groups, the molecule provides two chemically distinct positions that can be used in subsequent transformations.

Why Do the Two Halogens Matter?

The value of 5-Bromo-2-chloropyrimidine comes largely from its substitution pattern.

The bromine and chlorine atoms can behave differently under suitable reaction conditions. This can allow a chemist to functionalise one position while retaining the other for a subsequent transformation. APC specifically describes the compound’s differential reactivity as a key reason for its value as a pharmaceutical building block.

This creates an important synthetic advantage.

Instead of introducing two different functional groups independently onto a pyrimidine ring, a suitably substituted starting material can provide the required positions from the beginning.

The result is a useful platform for multi-step pharmaceutical synthesis.

Selective Functionalisation and Synthetic Flexibility

Pharmaceutical molecules are often assembled through several sequential reactions.

A synthetic route may require one position on a heterocyclic ring to undergo transformation while another position remains available for a later step.

This is where a compound such as 5-Bromo-2-chloropyrimidine becomes particularly useful.

Its two different halogen substituents provide opportunities for controlled functionalisation under suitable reaction conditions.

The precise reaction pathway depends on the target molecule, reaction conditions and process requirements, but the underlying principle is straightforward:

A carefully substituted starting material can give the synthesis greater control over what happens next.

That is one reason substituted pyrimidines are useful building blocks in pharmaceutical chemistry.

Why Substitution Position Matters

With heterocyclic intermediates, the position of each substituent can matter as much as the identity of the substituent itself.

Consider:

• 5-Bromo-2-chloropyrimidine
• 2-Bromo-5-chloropyrimidine

They contain the same elements and the same basic pyrimidine framework, but the positions of bromine and chlorine are reversed.

They are therefore different compounds with different structures and potentially different synthetic behaviour.

For a multi-step synthesis, that difference can be significant.

The intended substitution pattern needs to be established from the beginning because the downstream chemistry is designed around the structure of the starting intermediate.

This is why regioselectivity and structural identity matter when manufacturing pharmaceutical intermediates.

Where Is 5-Bromo-2-Chloropyrimidine Used?

Advance Pharma Chem lists 5-Bromo-2-chloropyrimidine as an intermediate used in the synthesis of several pharmaceutical compounds. Its product page identifies applications including:

• Aprocitentan, an endothelin receptor antagonist used in the treatment of resistant hypertension
• Macitentan, an endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension
• Obicetrapib, a CETP inhibitor being developed for lipid management

These applications illustrate the role of the compound as a building block rather than a final pharmaceutical product. The pyrimidine intermediate undergoes further chemical transformations within the relevant synthetic route.

Why Purity Matters for This Intermediate

For a compound used as a building block in subsequent synthesis, purity is not simply a number printed on a Certificate of Analysis.

The nature of the impurities matters too.

Advance Pharma Chem has reported achieving greater than 99.95% purity by HPLC for 5-Bromo-2-chloropyrimidine, with the result verified by three independent laboratories. The company states that this specification is available for sampling, qualification batches and commercial bulk supply.

That result becomes more meaningful when translated into parts per million.

A purity of 99.5% corresponds to approximately 5,000 ppm of impurities.

At 99.95%, that falls to approximately 500 ppm.

The difference looks small when expressed as a percentage. In a multi-step synthesis, however, the composition of the starting material can become an important part of the overall process.

What Does Higher Purity Mean for Downstream Synthesis?

An intermediate enters a reaction as a defined starting material. Whatever accompanies that material can potentially influence what happens next, depending on its chemical nature and the reaction conditions.

Unwanted components may therefore create additional analytical or purification considerations downstream.

This is particularly relevant when the intermediate is used repeatedly across a multi-step API synthesis.

A cleaner starting material does not automatically guarantee a successful downstream process, but it can reduce one source of variability that process chemists need to control.

For this reason, purity, impurity profile and batch consistency should be considered together, rather than treating the headline assay figure as the entire quality story.

From Laboratory Chemistry to Commercial Supply

Producing a compound once in a laboratory and manufacturing it consistently for commercial use are different challenges.

A commercial process needs to maintain control over:

• Raw-material inputs
• Reaction conditions
• Selectivity
• Isolation
• Purification
• Analytical testing
• Batch consistency

For 5-Bromo-2-chloropyrimidine, this means maintaining the intended molecular structure and quality characteristics from batch to batch.

Advance Pharma Chem lists the compound as part of its pharmaceutical intermediate portfolio and states that it supplies the material for development and commercial requirements.

Why Reaction Expertise Matters

The manufacture of a pharmaceutical intermediate is closely connected to the chemistry used to produce it.

For 5-Bromo-2-chloropyrimidine, the most relevant capabilities to consider are bromination, chlorination and Sandmeyer synthesis, alongside broader heterocyclic chemistry capabilities.

Advance Pharma Chem maintains a dedicated Reaction Capabilities platform covering these and other reaction types.

Explore Advance Pharma Chem’s Reaction Capabilities.

The important distinction is therefore between simply having a compound available and having the process chemistry capability to manufacture it consistently.

From Building Block to Pharmaceutical Molecule

A heterocyclic intermediate rarely represents the end of the synthetic route.

Instead, it provides a platform from which additional chemical transformations can build a more complex molecule.

The overall concept can be simplified as:

Heterocyclic scaffold → Functionalisation → Advanced intermediate → API

The number of steps and transformations varies by molecule, but the principle remains the same.

The value of the intermediate lies in giving the synthesis a chemically useful starting point for what comes next.

Advance Pharma Chem and 5-Bromo-2-Chloropyrimidine

Advance Pharma Chem manufactures 5-Bromo-2-chloropyrimidine (CAS 32779-36-5) as part of its pharmaceutical intermediate portfolio. The company’s product page identifies applications in the synthesis of Aprocitentan, Macitentan and Obicetrapib.

APC has also reported achieving >99.95% HPLC purity, with the result verified by three independent laboratories.

The company states that the material is available for sampling, qualification batches and commercial bulk supply.

For pharmaceutical companies evaluating 5-Bromo-2-chloropyrimidine manufacturers and suppliers in India, the discussion should therefore extend beyond availability and price to include the intended application, specification, analytical data and supply requirements.

View 5-Bromo-2-chloropyrimidine.

Frequently Asked Questions

What is 5-Bromo-2-chloropyrimidine used for?

5-Bromo-2-chloropyrimidine (CAS 32779-36-5) is a pharmaceutical intermediate used in the synthesis of Aprocitentan, Macitentan and Obicetrapib, according to Advance Pharma Chem’s product information.

Why is 5-Bromo-2-chloropyrimidine useful in pharmaceutical synthesis?

Its pyrimidine ring and two different halogen substituents provide opportunities for selective functionalisation during subsequent synthetic steps.

What is the CAS number of 5-Bromo-2-chloropyrimidine?

The CAS number is 32779-36-5. Its molecular formula is C₄H₂BrClN₂ and its molecular weight is 193.43 g/mol.

What is the purity of Advance Pharma Chem’s 5-Bromo-2-chloropyrimidine?

Advance Pharma Chem has reported >99.95% purity by HPLC, with the result verified by three independent laboratories.

Why does the position of bromine and chlorine matter?

The position of each substituent determines the molecular structure and influences how the compound can participate in subsequent chemical transformations. Reversing the positions produces a different compound with different synthetic behaviour.

Can 5-Bromo-2-chloropyrimidine be supplied for commercial manufacturing?

Yes. Advance Pharma Chem states that its material is available for sampling, qualification batches and commercial bulk supply.

What should buyers check when sourcing 5-Bromo-2-chloropyrimidine?

Buyers should evaluate the compound’s identity, purity, impurity profile, batch consistency, analytical documentation, intended application and the manufacturer’s ability to support qualification and commercial supply.

Conclusion

5-Bromo-2-chloropyrimidine demonstrates why the value of a pharmaceutical intermediate often lies in its molecular architecture.

Its pyrimidine framework, defined substitution pattern and different halogen substituents give chemists a useful platform for subsequent functionalisation and pharmaceutical synthesis.

For manufacturers, however, the chemistry is only part of the challenge. The intermediate also needs to be produced consistently, characterised accurately and supplied at a quality appropriate for its intended downstream process.

Advance Pharma Chem’s reported >99.95% HPLC purity, independently verified by three laboratories, provides a concrete example of that manufacturing focus.

For pharmaceutical companies evaluating 5-Bromo-2-chloropyrimidine manufacturers and suppliers in India, the right starting point is therefore not simply the product name or quoted price. It is the combination of molecular identity, purity, analytical evidence, manufacturing capability and supply reliability.